Werkgroep Cardiologische centra Nederland English

COMPASS-LTOLE (Follow up)

A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
Middel
rivaroxaban
Populatie
ASCVD
Fase
III
Jaar aanvang
2018